CAAS Capital Management’s Lux Health Tech Acquisition Corp LUXA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-52,200
Closed -$523K – 1104
2022
Q3
$523K Hold
52,200
– – 0.03% 486
2022
Q2
$516K Buy
+52,200
New +$515K 0.03% 515
2021
Q3
– Sell
-86,802
Closed -$858K – 1275
2021
Q2
$858K Sell
86,802
-29,989
-26% -$302K 0.01% 623
2021
Q1
$1.2M Sell
116,791
-33,209
-22% -$369K 0.01% 746
2020
Q4
$1.61M Buy
+150,000
New +$1.61M 0.02% 530

CAAS Capital Management's LUXA Position: Q4 2022 in Review

CAAS Capital Management sold out of Lux Health Tech Acquisition Corp (LUXA) in Q4 2022, closing a stake of 52,200 shares — an estimated $523K sold.

CAAS Capital Management first reported a position in LUXA in Q4 2020 and held it in 5 quarters. The position peaked at $1.61M in Q4 2020. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

  • CAAS Capital Management reported no remaining Lux Health Tech Acquisition Corp position as of Q4 2022 after selling out during the quarter.
  • CAAS Capital Management sold 52,200 Lux Health Tech Acquisition Corp shares in Q4 2022, an estimated $523K.
  • CAAS Capital Management first reported a position in Lux Health Tech Acquisition Corp in Q4 2020 and held it in 5 quarters.
  • CAAS Capital Management's Lux Health Tech Acquisition Corp position peaked at $1.61M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp as of Q4 2022.

Based on CAAS Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.